Related Experiment Videos
Ostip2, a novel oncoprotein that associates with the Rho exchange factor Ost
R Yamanaka1, R Blumenthal, M V Lorenzi
1Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
DNA and Cell Biology
|August 17, 2001
Summary
Researchers discovered OSTIP2, a novel oncoprotein interacting with the Ost protooncogene. OSTIP2 promotes cell transformation and tumor formation, highlighting its oncogenic potential in cancer research.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- The ost protooncogene encodes a guanine nucleotide exchange factor for Rho GTPases.
- The N-terminal domain of Ost negatively regulates its oncogenic activity.
Purpose of the Study:
- To identify proteins interacting with the N-terminal domain of Ost.
- To characterize the function and oncogenic potential of a novel interacting protein, OSTIP2.
Main Methods:
- Yeast two-hybrid system to identify interacting proteins.
- In vitro binding assays (GST pull-down).
- Cell transformation assays in NIH 3T3 cells and tumor induction in nude mice.
Main Results:
- Identified OSTIP2 as an Ost-interacting protein highly expressed in skeletal muscle.
- OSTIP2 induced morphological transformation of NIH 3T3 cells.
- OSTIP2 transfection led to significant tumor formation in athymic mice.
Conclusions:
- OSTIP2 is a novel oncoprotein that interacts with the Rho exchange factor Ost.
- OSTIP2 possesses oncogenic activity, promoting cell transformation and tumorigenesis.